MacroGenics Announces Achievement of $10 Million Milestone Following Gilead’s Exercise of Option to License Preclinical Bispecific Program

Go back to MacroGenics Announces Achievement of $10 Million Milestone Following Gilead’s Exercise of Option to License Preclinical Bispecific Program
MACROGENICS (NASDAQ: MGNX) Delayed: 4.17 +0.05 (1.21%)
Previous Close $4.12    52 Week High $36.11 
Open $4.17    52 Week Low $14.84 
Day High $4.20    P/E 10.69 
Day Low $4.15    EPS $0.39 
Volume 44,720